|
WO2000069810A1
(en)
|
1999-05-17 |
2000-11-23 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
JP2003500392A
(ja)
|
1999-05-25 |
2003-01-07 |
セプラコール， インク． |
複素環式鎮痛性化合物およびその使用方法
|
|
US6645980B1
(en)
|
2000-05-25 |
2003-11-11 |
Sepracor Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
|
IL154363A0
(en)
|
2000-09-25 |
2003-09-17 |
Actelion Pharmaceuticals Ltd |
Substituted amino-aza-cycloalkanes useful against malaria
|
|
FR2815032B1
(fr)
|
2000-10-10 |
2003-08-08 |
Pf Medicament |
Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
|
|
FR2825706B1
(fr)
|
2001-06-06 |
2003-12-12 |
Pf Medicament |
Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase
|
|
FR2839974B1
(fr)
|
2002-05-24 |
2004-07-16 |
Pf Medicament |
Derives de phenyl-furane ou de phenyl-thiophene,leur preparation et leur application a titre de medicament
|
|
AU2003249983A1
(en)
|
2002-07-18 |
2004-02-09 |
Actelion Pharmaceuticals Ltd |
Piperidines useful for the treatment of central nervous system disorders
|
|
BR0314126A
(pt)
|
2002-09-20 |
2005-06-28 |
Pfizer Prod Inc |
Ligandos de amida acìclica e sulfonamida para o receptor de estrogênio
|
|
WO2004046162A2
(en)
|
2002-11-14 |
2004-06-03 |
The Scripps Research Institute |
Non-steroidal fxr agonists
|
|
US7647217B2
(en)
|
2002-11-15 |
2010-01-12 |
The Salk Institute For Biological Studies |
Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
|
|
US20050143449A1
(en)
|
2002-11-15 |
2005-06-30 |
The Salk Institute For Biological Studies |
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
EP1648874B1
(en)
|
2003-07-30 |
2011-10-05 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
WO2005058822A1
(en)
|
2003-12-17 |
2005-06-30 |
Actelion Pharmaceuticals Ltd |
Substituted amino-cycloalkanes
|
|
CN1914205A
(zh)
|
2003-12-19 |
2007-02-14 |
葛兰素集团有限公司 |
吡唑并[3,4－b]吡啶化合物及其作为磷酸二酯酶抑制剂的用途
|
|
PL1734970T3
(pl)
|
2004-03-12 |
2015-05-29 |
Intercept Pharmaceuticals Inc |
Leczenie zwłóknienia z zastosowaniem ligandów FXR
|
|
WO2005097760A1
(en)
|
2004-03-26 |
2005-10-20 |
Rigel Pharmaceuticals, Inc. |
Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
|
|
WO2005113522A1
(en)
|
2004-05-07 |
2005-12-01 |
Janssen Pharmaceutica, N.V. |
Azole carboxamide inhibitors of bacterial type iii protein secretion systems
|
|
JP2006199656A
(ja)
|
2005-01-24 |
2006-08-03 |
Kowa Co |
アミド基を有する環状アミン化合物
|
|
MY144229A
(en)
|
2006-01-26 |
2011-08-15 |
Xenon Pharmaceuticals Inc |
Pyridazine derivatives and their use as therapeutic agents
|
|
CN101395170A
(zh)
|
2006-02-14 |
2009-03-25 |
英特塞普特药品公司 |
用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
|
|
EP2001851A2
(en)
|
2006-03-28 |
2008-12-17 |
Novartis AG |
Amide derivatives and their application for the treament of g protein related diseases
|
|
US20080081824A1
(en)
|
2006-09-29 |
2008-04-03 |
Bristol-Myers Squibb Company |
Substituted piperidines as modulators of chemokine receptor activity
|
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
|
EP2234977A4
(en)
|
2007-12-19 |
2011-04-13 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE INHIBITORS
|
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
WO2010001869A1
(ja)
|
2008-06-30 |
2010-01-07 |
武田薬品工業株式会社 |
４置換ベンゼン化合物およびその用途
|
|
JP2010077109A
(ja)
|
2008-08-28 |
2010-04-08 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
|
JP2012516885A
(ja)
|
2009-02-04 |
2012-07-26 |
ファイザー・インク |
４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体
|
|
EP2454243A2
(en)
|
2009-07-15 |
2012-05-23 |
Merck Serono SA |
Tetrazole derivatives
|
|
CA2767089A1
(en)
|
2009-07-15 |
2011-01-20 |
Abbott Laboratories |
Pyrrolopyridine inhibitors of kinases
|
|
FR2963005B1
(fr)
|
2010-07-23 |
2012-08-17 |
Sanofi Aventis |
Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
|
|
WO2012087521A1
(en)
|
2010-12-20 |
2012-06-28 |
Irm Llc |
Compositions and methods for modulating farnesoid x receptors
|
|
KR101834362B1
(ko)
|
2011-03-18 |
2018-03-05 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
N-(3-카바모일페닐)-1h-피라졸-5-카복사미드 유도체 및 동물 해충을 구제하기 위한 그의 용도
|
|
ME02754B
(me)
|
2011-03-23 |
2018-01-20 |
Trevena Inc |
Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
|
|
EP2732871A4
(en)
|
2011-07-13 |
2015-03-04 |
M Tech Co Ltd |
PROCESS FOR PRODUCING MICROPARTICLES WITH CONTROLLED CRYSTALLITE DIAMETER
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
WO2013037482A1
(en)
*
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
|
RU2543485C2
(ru)
|
2013-02-26 |
2015-03-10 |
Андрей Александрович Иващенко |
Гетероциклические агонисты рецепторов желчных кислот tgr5, фармацевтическая композиция, способы их получения и применения
|
|
DK3043865T3
(da)
*
|
2013-09-11 |
2021-02-01 |
Univ Claude Bernard Lyon |
Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
|
|
GB201316824D0
(en)
|
2013-09-23 |
2013-11-06 |
R & D Vernalis Ltd |
New Chemical Entities
|
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
KR20160132111A
(ko)
|
2014-03-13 |
2016-11-16 |
더 솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Fxr 작용제와 제조방법 및 용도
|
|
EP3116851B1
(en)
|
2014-03-13 |
2023-07-26 |
Salk Institute for Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
US10077268B2
(en)
|
2014-03-13 |
2018-09-18 |
Salk Institute For Biological Studies |
FXR agonists and methods for making and using
|
|
US20150258052A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissue
|
|
CN107427524A
(zh)
|
2014-08-28 |
2017-12-01 |
翁科埃斯克斯有限公司 |
利用包含噻吩并三唑并二氮杂*化合物的药物组合物治疗急性髓细胞白血病或急性淋巴性白血病的方法
|
|
US20180116993A1
(en)
|
2015-01-22 |
2018-05-03 |
Xiamen University |
Modulators of farnesoid x receptor and methods for the use thereof
|
|
AU2016233579A1
(en)
|
2015-03-13 |
2017-10-12 |
Salk Institute For Biological Studies |
Treating latent autoimmune diabetes of adults with farnesoid X receptor agonists to activate intestinal receptors
|
|
WO2017018751A1
(ko)
|
2015-07-24 |
2017-02-02 |
동국대학교 산학협력단 |
Blt 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 염증성 질환 예방 또는 치료용 조성물
|
|
US10626081B2
(en)
|
2015-09-16 |
2020-04-21 |
Metacrine, Inc. |
Farnesoid X receptor agonists and uses thereof
|
|
US10703712B2
(en)
*
|
2015-09-16 |
2020-07-07 |
Metacrine, Inc. |
Farnesoid X receptor agonists and uses thereof
|
|
WO2017049177A1
(en)
|
2015-09-16 |
2017-03-23 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
EP3350164A4
(en)
|
2015-09-16 |
2019-03-27 |
Metacrine, Inc. |
FARNESOID-X RECEPTOR AGONISTS AND USES THEREOF
|
|
MX389514B
(es)
|
2015-10-01 |
2025-03-20 |
Firmenich Incorporated |
Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
|
|
CN105477636B
(zh)
|
2015-10-16 |
2019-09-17 |
厦门大学 |
使用阿维菌素及其衍生物治疗代谢疾病的方法
|
|
WO2017078928A1
(en)
|
2015-11-06 |
2017-05-11 |
Salk Institute For Biological Studies |
Fxr agonists and methods for making and using
|
|
CN107126419B
(zh)
*
|
2016-02-26 |
2020-06-19 |
石药集团中诺药业（石家庄）有限公司 |
一种奥贝胆酸片剂及其制备方法
|
|
WO2017170182A1
(ja)
|
2016-03-31 |
2017-10-05 |
株式会社Adeka |
感光性組成物及び新規化合物
|
|
WO2018170165A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2018170167A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
JP7258763B2
(ja)
*
|
2017-03-15 |
2023-04-17 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストおよびその使用
|
|
US20200131129A1
(en)
|
2017-03-15 |
2020-04-30 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CA3055990A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CZ2017298A3
(cs)
*
|
2017-05-26 |
2018-12-05 |
Zentiva, K.S. |
Amorfní formy obeticholové kyseliny
|
|
CN110996913A
(zh)
|
2017-06-30 |
2020-04-10 |
欧恩科斯欧公司 |
新的贝利司他口服制剂
|
|
EA039150B1
(ru)
|
2017-07-03 |
2021-12-10 |
Онксео |
Новые пероральные составы на основе белиностата
|
|
US20210290541A1
(en)
|
2018-07-30 |
2021-09-23 |
Chugai Seiyaku Kabushiki Kaisha |
Solid dispersion of hydantoin derivative
|
|
WO2020060007A1
(ko)
|
2018-09-17 |
2020-03-26 |
엘지전자 주식회사 |
5g 이동통신에서 pdu 세션을 핸들링하는 방법 및 무선 기기
|
|
EP3852749A4
(en)
|
2018-09-18 |
2022-08-24 |
Metacrine, Inc. |
CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST
|
|
AU2019344903B2
(en)
|
2018-09-18 |
2025-02-27 |
Eli Lilly And Company |
Farnesoid X receptor agonists and uses thereof
|
|
WO2020061118A1
(en)
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2020061116A1
(en)
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
JP2022500393A
(ja)
|
2018-09-18 |
2022-01-04 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストおよびその使用
|
|
CN113056264A
(zh)
|
2018-09-18 |
2021-06-29 |
梅塔科林公司 |
法尼醇x受体激动剂及其用途
|
|
EA202190661A1
(ru)
|
2018-09-18 |
2021-08-13 |
Метакрайн, Инк. |
Агонисты фарнезоидного х-рецептора для лечения заболевания
|
|
CN120732855A
(zh)
|
2020-03-18 |
2025-10-03 |
伊莱利利公司 |
用于治疗疾病的法尼醇x受体激动剂
|
|
KR20220155356A
(ko)
|
2020-03-18 |
2022-11-22 |
메타크린, 인크. |
파르네소이드 x 수용체 효능제의 결정형
|
|
WO2021188695A1
(en)
|
2020-03-18 |
2021-09-23 |
Metacrine, Inc. |
Formulations of a farnesoid x receptor agonist
|